glp-1 employer healthcare costs 68% of Users Say Cost Influenced Their Treatment Decisions Employers Weighing the Obesity Drug

Wang CF et al

In addition, combining GLP-1RAs with other therapeutic agents, such as sodium-glucose cotransporter 2 inhibitors (SGLT2i), has shown synergistic effects in reducing liver stiffness and improving overall liver health (Lin et al., 2024)

GLP-1 agonists might protect the heart indirectly through their effects on weight, blood sugar, blood pressure, and inflammation

Irfan Khan provides personalized insights into these medications, helping patients choose the right GLP-1 option for their weight loss journey

The disadvantage is the metabolic disruption of stopping and starting, which may reduce the efficiency of subsequent treatment courses

No specific clinical result is promised or guaranteed